Dublin, November 02, 2021 (GLOBE NEWSWIRE) – The “United States Pacemaker Market, By Type (MRI Compatible Pacemakers, Conventional Pacemakers), By Product Type (Implantable Pacemaker, External Pacemaker), By Application, By Technology , by End The report “User, by Region, Forecast and Opportunity, 2026” has been added to ResearchAndMarkets.com offer.
The US pacemaker market is expected to experience a healthy CAGR during the forecast period.
Increased cases of COVID-19, which has resulted in increased spread of cardiovascular disease among patients with coronavirus, which acts as a major growth engine for the pacemaker market in the country.
Along with this, favorable reimbursement procedures such as Medicare system and increasing demand for minimally invasive procedures are key factors propelling the growth of the US pacemaker market. The increase in the geriatric population, more vulnerable to cardiovascular disease, is also fueling the demand for pacemakers in the country.
Additionally, the advent of battery-less pacemakers and increasing FDA approval for new pacemakers are expected to drive the market growth through 2026.
In addition, the launch of new products such as wireless pacemakers and MRI safe pacemakers are increasing the pacemaker market in the United States. In addition, the high disposable income per capita and increasing healthcare spending are expected to drive the market growth in the coming years.
The U.S. Pacemaker Market is categorized on the basis of Type, Product Type, Application, Technology, End User, and Region. On the basis of technology, the market can be segmented into single chamber, dual chamber, and CRT-P / biventricular pacemakers.
Among them, CRT-P, also known as biventricular pacemaker, is expected to experience the fastest growth during the forecast period. These pacemakers contain three leads, which are connected to the right atrium and both ventricles and are increasingly used to treat people with arrhythmias caused by advanced heart failure.
Based on the end user, the US pacemaker market can be segmented into hospitals and cardiac centers and outpatient surgical centers. Among them, the segment of outpatient surgery centers is expected to experience significant growth in terms of revenue during the forecast period due to the increasing need to reduce surgical and post-surgical expenses and the increasing prevalence of CVD in the country. .
Major market players are adopting growth strategies, including new product launches, partnerships and collaborations, and mergers and acquisitions, in order to increase their share in the pacemaker market.
The major players operating in the US pacemaker market include
- Biotronik, Inc.
- Boston Scientific Society
- Abbot inc.
- Zoll Medical Society
- Oscor inc.
- Medtronic, Inc.
- Cordis, Inc.
- Livanova PLC
- Médico inc.
- Oscor inc.
- Osypka Medical inc.
Scope of the report:
Years considered for this report:
- Historical years: 2016-2019
- Baseline year: 2020
- Estimated year: 2021
- Forecast period: 2022-2026
United States Pacemaker Market, By Type
- MRI-compatible pacemakers
- Conventional heart pacemakers
United States Pacemaker Market, By Product Type
- Implantable pacemaker
- External pacemaker
United States Pacemaker Market, By Application
- Heart block
- Atrial fibrillation
- Long QT syndrome
United States Pacemaker Market, By Technology
- Single room
- Double room
- CRT-P / biventricular pacemaker
United States Pacemaker Market, By End User
- Hospitals and heart centers
- Outpatient surgical centers
Main topics covered:
1. Product overview
2. Research methodology
3. Impact of COVID-19 on the US Pacemaker Market
4. Executive summary
5. Voice of the customer
6. United States Pacemaker Market Outlook
7. United States Implantable Pacemaker Market Outlook
8. US External Pacemaker Market Outlook
9. Market dynamics
10. Market trends and development
11. Political and regulatory landscape
12. Export import analysis
13. Economic Profile of the United States
14. Competitive landscape
15. Strategic recommendations
For more information on this report visit https://www.researchandmarkets.com/r/b2vn81